Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""selective serotonin reuptake inhibitors."" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 4861
Tytuł:
Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two-year period of pharmacotherapy.
Autorzy:
Mori K; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Kodaka F; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Yamamoto A; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Yamazaki R; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Ishii J; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Yamadera W; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.; Department of Psychiatry, Jikei University Katsushika Medical Center, Tokyo, Japan.
Miyata H; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Shigeta M; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 67-72. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:
Journal Article
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*
Anti-Anxiety Agents*
Humans ; Female ; Anxiety Disorders ; Benzodiazepines ; Prescriptions
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of drug holidays on sexual dysfunction in men treated with selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine: an 8-week open-label randomized clinical trial.
Autorzy:
Alipour-Kivi A; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Eissazade N; Brain and Cognition Clinic, Institute for Cognitive Sciences Studies, Tehran, Iran.
Shariat SV; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Salehian R; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Soraya S; Research Center for Addiction and Risky Behaviors (ReCARB), Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Askari S; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Shalbafan M; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Jan 23; Vol. 24 (1), pp. 67. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Fluoxetine*
Selective Serotonin Reuptake Inhibitors*
Humans ; Male ; Ambulatory Care Facilities ; Iran ; Treatment Interruption ; Adolescent ; Young Adult ; Adult ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effect of SSRIs on fear learning: a systematic review and meta-analysis.
Autorzy:
Heesbeen EJ; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Bijlsma EY; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Verdouw PM; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
van Lissa C; Department of Methodology, Tilburg University, Tilburg, Netherlands.
Hooijmans C; Department of Anaesthesiology, Pain and Palliative Care, Radboud University Medical Center, Nijmegen, Netherlands.
Groenink L; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2023 Nov; Vol. 240 (11), pp. 2335-2359. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/pharmacology
Stress Disorders, Post-Traumatic*/drug therapy
Animals ; Humans ; Bayes Theorem ; Fear ; Anxiety Disorders/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Baseline cognitive functioning can predict the trajectory of acute treatment in first-episode major depressive disorder.
Autorzy:
Liu S; Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, 030001, China.; Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
Tong Y; Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, 030001, China.; Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
Wang X; Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, 030001, China.; Shanxi Key Laboratory of Artificial Intelligence Assisted Diagnosis and Treatment for Mental Disorder, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
Yu X; Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, 100191, China. .
Xu Y; Department of Psychiatry, First Hospital/First Clinical Medical College of Shanxi Medical University, Taiyuan, 030001, China. .; Shanxi Provincial Key Laboratory of Brain Science and Neuropsychiatric Diseases, Shanxi Medical University, Taiyuan, 030001, China. .; Department of Mental Health, Shanxi Medical University, Taiyuan, 030001, China. .
Pokaż więcej
Źródło:
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2023 Aug; Vol. 273 (5), pp. 1129-1137. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/pharmacology
Selective Serotonin Reuptake Inhibitors*/therapeutic use
Depressive Disorder, Major*/complications
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/psychology
Humans ; Cognition ; Psychiatric Status Rating Scales ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using machine learning to develop a clinical prediction model for SSRI-associated bleeding: a feasibility study.
Autorzy:
Goyal J; Donald Bren School of Information and Computer Sciences, University of California Irvine, Irvine, CA, USA.
Ng DQ; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
Zhang K; Donald Bren School of Information and Computer Sciences, University of California Irvine, Irvine, CA, USA.
Chan A; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
Lee J; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
Zheng K; Donald Bren School of Information and Computer Sciences, University of California Irvine, Irvine, CA, USA.
Hurley-Kim K; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
Nguyen L; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
He L; Donald Bren School of Information and Computer Sciences, University of California Irvine, Irvine, CA, USA.
Nguyen M; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
McBane S; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA.
Li W; Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA, USA.
Cadiz CL; Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 802 W Peltason Dr, Irvine, CA, 92697-4625, USA. .
Pokaż więcej
Źródło:
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2023 Jun 11; Vol. 23 (1), pp. 105. Date of Electronic Publication: 2023 Jun 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/adverse effects
Population Health*
Humans ; United States ; Adolescent ; Feasibility Studies ; Escitalopram ; Models, Statistical ; Prognosis ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exploring the association between selective serotonin reuptake inhibitors and rhabdomyolysis risk based on the FDA pharmacovigilance database.
Autorzy:
Wang Y; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Lin Y; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Lin Q; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Liang H; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.
Cai W; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China. .
Jiang D; Department of Pharmacy, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 28; Vol. 13 (1), pp. 12257. Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/adverse effects
Rhabdomyolysis*/chemically induced
Rhabdomyolysis*/epidemiology
United States/epidemiology ; Humans ; Bayes Theorem ; Pharmacovigilance ; Fluvoxamine ; Paroxetine ; Adverse Drug Reaction Reporting Systems ; United States Food and Drug Administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development of a Green Microwell Spectrofluorimetric Assay with High Analytical Throughput for the Determination of Selective Serotonin Reuptake Inhibitors in Pharmaceutical Dosage Forms and Plasma.
Autorzy:
Alzoman NZ; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Darwish IA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jul 05; Vol. 28 (13). Date of Electronic Publication: 2023 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*
Fluvoxamine*
Spectrometry, Fluorescence/methods ; Plasma ; Pharmaceutical Preparations
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
Autorzy:
Zhang J; Department of Pharmacy, Tianjin Second People's Hospital, Tianjin, China.
Zheng X; Department of Pharmacy, Tianjin Union Medical Center, Tianjin, China.
Zhao Z; Department of Pharmacy, Tianjin Union Medical Center, Tianjin, China. .
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2023 May 31; Vol. 23 (1), pp. 210. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/therapeutic use
Alzheimer Disease*/complications
Alzheimer Disease*/drug therapy
Humans ; Depression/drug therapy ; Depression/etiology ; Sertraline/therapeutic use ; Escitalopram
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and Validation of Green and High-Throughput Microwell Spectrophotometric Assay for the Determination of Selective Serotonin Reuptake Inhibitors in Their Pharmaceutical Dosage Forms.
Autorzy:
Darwish IA; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Alzoman NZ; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 May 21; Vol. 28 (10). Date of Electronic Publication: 2023 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*
Fluoxetine*
Spectrophotometry/methods ; Fluvoxamine ; Pharmaceutical Preparations
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
Autorzy:
Stefánsdóttir ÍH; Faculty of Psychology, University of Iceland, Reykjavík, Iceland.
Ivarsson T; Institute of Neuroscience and Physiology, University of Gothenburg, Goteborg, Sweden.
Skarphedinsson G; Faculty of Psychology, University of Iceland, Reykjavík, Iceland.
Pokaż więcej
Źródło:
Nordic journal of psychiatry [Nord J Psychiatry] 2023 Feb; Vol. 77 (2), pp. 137-146. Date of Electronic Publication: 2022 May 19.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Anxiety Disorders*/drug therapy
Selective Serotonin Reuptake Inhibitors*/adverse effects
Selective Serotonin Reuptake Inhibitors*/therapeutic use
Serotonin and Noradrenaline Reuptake Inhibitors*/adverse effects
Serotonin and Noradrenaline Reuptake Inhibitors*/therapeutic use
Adolescent ; Child ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trial.
Autorzy:
Maier HB; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany. .
Neyazi A; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany.; Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg (OVGU), Magdeburg, Germany.
Bundies GL; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany.
Meyer-Bockenkamp F; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany.
Bleich S; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany.
Pathak H; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany.
Ziert Y; Institute of Biostatistics, Hannover Medical School, Hannover, Germany.
Neuhaus B; Center for Clinial Trials (ZKS), Hannover Medical School, Hannover, Germany.
Müller FJ; Department of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel, Germany.; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Pollmann I; Department of Psychiatry and Psychotherapy, University Hospital Schleswig Holstein, Kiel, Germany.
Illig T; Hannover Unified Biobank, Hannover Medical School, Hannover, Germany.
Mücke S; Hannover Unified Biobank, Hannover Medical School, Hannover, Germany.
Müller M; Department of Biomarker Analysis and Development, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany.
Möller BK; Department of Biomarker Analysis and Development, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany.
Oeltze-Jafra S; Peter L. Reichertz Institute for Medical Informatics, Hannover Medical School, Hannover, Germany.
Kacprowski T; Division Data Science in Biomedicine, Peter L. Reichertz Institute of Technische Universität Braunschweig and Hannover Medical School, Braunschweig, Germany.; Braunschweig Integrated Centre for Systems Biology, Technische Universität Braunschweig, Braunschweig, Germany.
Voges J; Institut Für Informationsverarbeitung, Leibniz University Hannover, Hannover, Germany.
Müntefering F; Institut Für Informationsverarbeitung, Leibniz University Hannover, Hannover, Germany.
Scheiber J; BioVariance GmbH, Tirschenreuth, Germany.
Reif A; Department for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt, Germany.; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, Frankfurt Am Main, 60596, Germany.
Aichholzer M; Department for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt, Germany.
Reif-Leonhard C; Department for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt, Germany.
Schmidt-Kassow M; Department for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt, Germany.
Hegerl U; German Foundation for Depression and Suicide Prevention, Leipzig, Germany.; Senckenberg Distinguished Professorship, Department of Psychiatry, Psychosomatics, and Psychotherapy, Goethe Universität Frankfurt Am Main, Frankfurt, Germany.
Reich H; Department for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt, Germany.; German Foundation for Depression and Suicide Prevention, Leipzig, Germany.
Unterecker S; Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg (UKW), Würzburg, Germany.
Weber H; Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg (UKW), Würzburg, Germany.
Deckert J; Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg (UKW), Würzburg, Germany.
Bössel-Debbert N; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Grabe HJ; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Lucht M; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Frieling H; Department of Psychiatry, Social Psychiatry, and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 09; Vol. 25 (1), pp. 247. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Brain-Derived Neurotrophic Factor*/genetics
Depressive Disorder, Major*/diagnosis
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/genetics
Humans ; Prospective Studies ; Antidepressive Agents/adverse effects ; Selective Serotonin Reuptake Inhibitors ; Methylation ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open-labeled randomized control trial.
Autorzy:
Chen H; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin Y; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.; Department of Neurology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, China.
Zhao Z; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin T; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Lin Q; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chen X; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wu W; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Zeng G; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Wu S; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Liu N; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Chen H; Gynecology Department, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Chen R; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Xiao Y; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Mar; Vol. 30 (3), pp. e14650.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Anti-Anxiety Agents*
Isoindoles*
Medically Unexplained Symptoms*
Piperazines*
Pyrimidines*
Vascular Depression*
Humans ; Citrates ; Depression/drug therapy ; Selective Serotonin Reuptake Inhibitors ; Serotonin ; Treatment Outcome ; Venlafaxine Hydrochloride/therapeutic use ; Drug Therapy, Combination/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Functional brain responses to emotional faces after three to five weeks of intake of escitalopram in healthy individuals: a double-blind, placebo-controlled randomised study.
Autorzy:
Armand S; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Psychology, Faculty of Social Sciences, University of Copenhagen, Copenhagen, Denmark.
Langley C; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Johansen A; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Ozenne B; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Overgaard-Hansen O; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Larsen K; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jensen PS; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Knudsen GM; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Sahakian BJ; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Stenbæk DS; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. .; Department of Psychology, Faculty of Social Sciences, University of Copenhagen, Copenhagen, Denmark. .
Fisher PM; Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 3149. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Escitalopram*
Citalopram*/therapeutic use
Humans ; Emotions/physiology ; Selective Serotonin Reuptake Inhibitors/pharmacology ; Brain/diagnostic imaging ; Magnetic Resonance Imaging ; Double-Blind Method ; Facial Expression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Psychedelics and sexual functioning: a mixed-methods study.
Autorzy:
Barba T; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK. .
Kettner H; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.; Psychedelics Division, Neuroscape, Department of Neurology, University of California San Francisco, San Francisco, United States.
Radu C; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
Peill JM; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
Roseman L; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
Nutt DJ; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
Erritzoe D; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
Carhart-Harris R; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.; Psychedelics Division, Neuroscape, Department of Neurology, University of California San Francisco, San Francisco, United States.
Giribaldi B; Department of Medicine, Centre for Psychedelic Research, Imperial College London, London, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 07; Vol. 14 (1), pp. 2181. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Hallucinogens*/adverse effects
Humans ; Sexual Behavior/psychology ; Psilocybin/pharmacology ; Psilocybin/therapeutic use ; Escitalopram ; Selective Serotonin Reuptake Inhibitors/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The promise of N-acetylcysteine in the treatment of obsessive-compulsive disorder.
Autorzy:
Carollo M; Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Carollo N; Department of Medicine, University of Verona, Verona, Italy.
Montan G; Department of Women's and Children's Health, University of Padova, Padova, Italy.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Feb; Vol. 30 (2), pp. e14653.
Typ publikacji:
Journal Article
MeSH Terms:
Acetylcysteine*/therapeutic use
Obsessive-Compulsive Disorder*/drug therapy
Humans ; Selective Serotonin Reuptake Inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
Autorzy:
Amada N; Department of CNS Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Hirose T; Department of CNS Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Suzuki M; Department of CNS Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Kakumoto Y; Department of Lead Discovery Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Futamura T; Department of CNS Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Maeda K; Department of Lead Discovery Research, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Kikuchi T; Pharmaceutical Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Mar; Vol. 43 (1), pp. 132-136. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*
Depressive Disorder, Major*/drug therapy
Mice ; Animals ; Fluoxetine/pharmacology ; Paroxetine/pharmacology ; Paroxetine/therapeutic use ; Sertraline/pharmacology ; Swimming ; Escitalopram ; Antidepressive Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials.
Autorzy:
Suhas S; Department of Psychiatry, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Malo PK; Department of Biostatistics, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Kumar V; Department of Psychiatry, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Issac TG; Department of Psychiatry, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Chithra NK; Department of Psychiatry, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Bhaskarapillai B; Department of Biostatistics, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Reddy YCJ; Department of Psychiatry, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Rao NP; Department of Psychiatry, National Institute of Mental Health and Neurosciences [NIMHANS], Bangalore, India.
Pokaż więcej
Źródło:
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry [World J Biol Psychiatry] 2023 Feb; Vol. 24 (2), pp. 162-177. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*
Obsessive-Compulsive Disorder*/psychology
Adult ; Child ; Humans ; Aripiprazole/therapeutic use ; Ondansetron/therapeutic use ; Network Meta-Analysis ; Chronic Disease ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.
Autorzy:
Arnardóttir A; Faculty of Psychology, University of Iceland, Reykjavik, Iceland.
Skarphedinsson G; Faculty of Psychology, University of Iceland, Reykjavik, Iceland.
Pokaż więcej
Źródło:
Nordic journal of psychiatry [Nord J Psychiatry] 2023 Feb; Vol. 77 (2), pp. 118-126. Date of Electronic Publication: 2022 May 04.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/therapeutic use
Serotonin*
Female ; Adolescent ; Child ; Humans ; Male ; Network Meta-Analysis ; Norepinephrine ; Anxiety Disorders/drug therapy ; Anxiety ; Cognition
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Graphical methods for understanding changes in states: Understanding medication use pathways.
Autorzy:
Wise EA; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview and Johns Hopkins University, Baltimore, Maryland, USA.
Adams RJ; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview and Johns Hopkins University, Baltimore, Maryland, USA.
Lyketsos CG; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview and Johns Hopkins University, Baltimore, Maryland, USA.
Leoutsakos JM; Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview and Johns Hopkins University, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
International journal of methods in psychiatric research [Int J Methods Psychiatr Res] 2022 Dec; Vol. 31 (4), pp. e1932. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Selective Serotonin Reuptake Inhibitors*/pharmacology
Selective Serotonin Reuptake Inhibitors*/therapeutic use
Antidepressive Agents*/pharmacology
Antidepressive Agents*/therapeutic use
Humans ; Aged ; Prospective Studies ; Citalopram/therapeutic use ; Sertraline/pharmacology ; Sertraline/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis.
Autorzy:
Yin J; Department of Pharmacy, Huaihe Hospital, Henan University, Kaifeng, China.; National International Cooperation Base of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Song X; Department of Pharmacy, Huaihe Hospital, Henan University, Kaifeng, China.
Wang C; Department of General Surgery, Huaihe Hospital, Henan University, Kaifeng, China.
Lin X; Department of Clinical Laboratory, Huaihe Hospital, Henan University, Henan, China. .
Miao M; National International Cooperation Base of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, China. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2023 Nov 24; Vol. 23 (1), pp. 876. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Humans ; Escitalopram ; Citalopram/therapeutic use ; Antidepressive Agents/therapeutic use ; Selective Serotonin Reuptake Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 4861

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies